NCT06164665View on ClinicalTrials.gov

Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
High Altitude
Interventions
DRUG

Pioglitazone 15mg

Pioglitazone (PIO) will be administered as a 15 mg oral dose per day for 5 days

OTHER

Placebo

100% microcrystalline cellulos

Trial Locations (1)

01760

US Army Research Institute of Environmental Medicine, Natick

All Listed Sponsors
lead

United States Army Research Institute of Environmental Medicine

FED